Correction to: Performance of 99mTc-aprotinin scintigraphy for diagnosing light chain (AL) cardiac amyloidosis confirmed by endomyocardial biopsy

Toru Awaya; Ryogo Minamimoto; Kentaro Iwama; Shuji Kubota; Masatoshi Hotta; Risen Hirai; Masaya Yamamoto; Osamu Okazaki; Hisao Hara; Yukio Hiroi; Michiaki Hiroe; Masao Moroi

doi:10.1007/s12350-020-02229-7

Correction to: Performance of ^99mTc-aprotinin scintigraphy for diagnosing light chain (AL) cardiac amyloidosis confirmed by endomyocardial biopsy

J Nucl Cardiol. 2020 Aug;27(4):1154. doi: 10.1007/s12350-020-02229-7.

Authors

Toru Awaya^{1

2}, Ryogo Minamimoto³, Kentaro Iwama⁴, Shuji Kubota⁵, Masatoshi Hotta³, Risen Hirai⁶, Masaya Yamamoto⁵, Osamu Okazaki⁵, Hisao Hara⁵, Yukio Hiroi⁵, Michiaki Hiroe⁵, Masao Moroi⁷

Affiliations

¹ Department of Cardiovascular Medicine, National Center for Global Health and Medicine, Tokyo, Japan. toru0228@gmail.com.
² Division of Cardiovascular Medicine, Toho University Medical Center Ohashi Hospital, Tokyo, Japan. toru0228@gmail.com.
³ Division of Nuclear Medicine, National Center for Global Health and Medicine, Tokyo, Japan.
⁴ Department of Cardiovascular Medicine, The University of Tokyo, Tokyo, Japan.
⁵ Department of Cardiovascular Medicine, National Center for Global Health and Medicine, Tokyo, Japan.
⁶ Department of Hematology, Internal Medicine, Tokyo-Kita Medical Center, Tokyo, Japan.
⁷ Division of Cardiovascular Medicine, Toho University Medical Center Ohashi Hospital, Tokyo, Japan.

PMID: 32557240
DOI: 10.1007/s12350-020-02229-7

Abstract

This prospective study was conducted according to the principles outlined within the Declaration of Helsinki, and approved by the Ethics Review Board of National Center for Global Health and Medicine (NCGM-G-00839-01, NCGM-G-00839-02).

Publication types

Published Erratum